HB 490 – Kentucky
Status: In ProcessYear Introduced: 2024
Link: https://apps.legislature.ky.gov/record/24RS/hb490.html
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Key Issues:
340B Drug Pricing Program
PHARMACEUTICALS
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found